HealthFrance Official institution
Hospitals told to recall Mitomycine Accord 20 mg vials
French health authorities have published a recall notice for Mitomycine Accord 20 mg, a powder used to make an injectable solution, sold as a single vial. The product is made by Accord Healthcare France SAS. The recall is aimed at hospitals, and the notice was published on 3 November 2026.
This summary was generated by AI; the official source prevails.
What does it mean?
Hospitals that have this 20 mg powder vial in stock are being asked to pull it from use. Patients receiving treatment with this medicine could be affected by the change in supply.
Who is affected?
Hospitals and clinics holding stock of Mitomycine Accord 20 mg vials, and the patients they treat with it.